In this episode, BioSpace’s Head of Insights Lori Ellis, Miguel Forte and Ali Pashazadeh, Treehill Partners CEO, speculate on the impending Trump administration, discuss current challenges faced by CEOs, and weigh investment in GLP-1s.
2025 is set to change the industry. The new U.S. administration is poised to challenge many existing processes.
This is episode 2 of the discussion:
https://www.biospace.com/business/analysis-vs-beliefs-ceo-challenges-glp-1-investments